Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

Global Silicone Adhesives Market Surges as Electric Vehicle Manufacturing Drives Innovation in Bonding SolutionsRockville, MD, March 24, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...

Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant ...

Understanding your blood sugar levels after eating is a key part of maintaining overall health. Whether you’re managing ...

Discover 10 powerful lifestyle modifications that can prevent and potentially reverse type 2 diabetes naturally, from ...

Diabetes during pregnancy, whether type 1, type 2, or gestational diabetes, significantly increases the risk of complications for both mother and fetus.

Singapore (NRF) visited Imperial's IN-CYPHER team at CREATE to discover how our convergence science is building momentum across the region.John Lim ...

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...

A Review of the Latest Innovations,” published in the February 2025 issue of Journal of Clinical Endocrinology & Metabolism ...

For individuals with T1D, low-glucose alerts improve the time below range for drivers and reduce the incidence of low glucose while driving.